6 NEWS
6 NEWS
14 FEBRUARY 2025 ausdoc . com . au
Mayor bans ‘ illness ’ from village
Facebook |
Paul Smith FORGET doctors , hospitals , wonder drugs and those interminable debates |
|
|
|
Like many towns across Australia , it is also dealing with the realities of a long-running medical workforce |
measures , with residents asked “ not to engage in behaviours that may be harmful and to avoid domestic acci- |
“ I want to know if they feel safe ,” Mr Torchia said .
He said he had been waiting since
|
|
about where the money is coming |
shortage , which the nation ’ s pollies |
dents ”, along with instructions not |
June last year for new health ser- |
|
from to fund it all . |
have failed to address . |
to leave the house too often , travel or |
vices , describing access to healthcare |
|
The mayor of a small Italian village |
Half its residents are aged over 65 , |
practise sports , and to “ rest for the |
as a constitutional right . |
|
has come up with a fix : a decree ban- |
but the village doctor is unable to open |
majority of the time ”. |
Eighteen hospitals in Calabria |
|
ning its 1200 inhabitants from “ con- |
after hours and during weekends and |
The mayor , who said his frustra- |
have closed since 2009 , with media |
|
tracting any illness that may require |
the nearest ED is 40km away . |
tion was exacerbated by the political |
reports suggesting that political |
|
emergency medical assistance ”. |
“ It ’ s hard to feel safe when you |
indifference to what was happening |
mismanagement and mafia inter- |
|
Issued by Antonio Torchia , the |
know that , if you need assistance , |
to his community , wanted authorities |
ference had devastated the health- |
Mayor Antonio Torchia . |
decree was triggered by the struggles of the Belcastro community to access healthcare . |
your only hope is to make it to [ ED ] on time ,” Mr Torchia told Italian TV .
His decree also included preventive
|
|
|
to come and live in Belcastro , based in the Calabria region of southern Italy , for a week . |
care system , which is now under special administration by central government . |
RSV infections can occur all year round * 1,2
* Infections peak in the cooler months in temperate regions and after the rainy season in tropical regions in Australia . 1-3
Protection against RSV-LRTD starts with AREXVY †
†
AREXVY is indicated for active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus ( RSV ). Vaccines may not protect all recipients . 4
AREXVY has data on efficacy against RSV-LRTD over ~ 18 months in adults aged ≥60 years ‡ 5 , 6
‡
Median follow-up of 17.8 months , or over two RSV seasons . 5 , 6
SCAN OR VISIT GSKPRO . COM
TO LEARN MORE
Hypothetical patients for illustrative purposes only .
SCAN QR CODE to see full AREXVY
Product Information
Murder of aspiring doctor
PAGE 5 anything to see her daughter ’ s face “ just one more time ”.
“ Instead , I sit by her grave every Friday , stroking the grass because I can no longer stroke her hair ,” she said .
“ I kiss and hug her tombstone , longing to hold her and smell her .”
AMA Victoria president Dr Jill Tomlinson told Australian Doctor that non-fatal strangulation was a “ huge ” red flag .
“ The domestic violence homicides we see are often preceded by an instance of non-fatal strangulation , as you ’ ve seen in this case ,” she said .
Other red flags included multiple or recurrent strangulations , increasing frequency of violence , if women were pregnant or postpartum , or if there was an accessible weapon in the home , she said .
“ GPs , and all healthcare practitioners , have a role in specifically asking about non-fatal strangulation , because sometimes it won ’ t be disclosed .
“ It is important that GPs not fear asking the question , and that they recognise they can save a life by identifying this red flag .” J Emerg Med 2007 ; 25 Oct .
If this news story has raised issues for you , or you are concerned about someone you know , call Lifeline on 13 11 14 . You can also contact your local Doctors ’ Health Advisory Service .
Dosing and administration : AREXVY is administered as a single , reconstituted dose of 0.5 mL by intramuscular injection . The need for revaccination has not been established . Safety : Very common adverse events ( ≥10 %) are headache , myalgia , arthralgia , injection site pain and fatigue . Common adverse events ( ≥1 %) are injection site erythema , injection site swelling , fever , chills and rhinorrhoea ( not a complete list ; see full PI ). 4
PBS Information : AREXVY is not listed on the PBS or the National Immunisation Program ( NIP ).
Please review Product Information before prescribing . Product Information can be accessed at www . gsk . com . au / arexvy ▼This medicinal product is subject to additional monitoring in Australia . This will allow quick identification of new safety information . Healthcare professionals are asked to report any suspected adverse events at www . tga . gov . au / reportingproblems . RSV , respiratory syncytial virus ; RSV-LRTD , RSV-related lower respiratory tract disease . References : 1 . Di Giallonardo F et al . Viruses 2018 ; 10 ( 9 ): 476 . 2 . Paynter S et al . Aust N Z J Public Health 2015 ; 39 ( 1 ): 8 – 10 . 3 . Obando-Pacheco P et al . J Infect Dis 2018 ; 217 ( 9 ): 1356 – 64 . 4 . AREXVY Product Information . 5 . Papi A et al . N Engl J Med 2023 ; 388 ( 7 ): 595 – 608 . 6 . Ison MG et al . Clin Infect Dis 2024 ; 78 ( 6 ): 1732 – 44 . For information on GSK products or to report an adverse event involving a GSK product , please contact GSK Medical Information on 1800 033 109 . © 2024 GSK group of companies or its licensor . Trade marks are owned by or licensed to the GSK group of companies . GlaxoSmithKline Australia Pty Ltd , Melbourne , VIC . PM-AU-RSA-JRNA-240004 . Date of approval : October 2024 .
Armina Hayat .